These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Pemmaraju N; Madanat YF; Rizzieri D; Fazal S; Rampal R; Mannis G; Wang ES; Foran J; Lane AA Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126 [TBL] [Abstract][Full Text] [Related]
6. Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Wilson NR; Pemmaraju N Expert Opin Pharmacother; 2022 Mar; 23(4):431-438. PubMed ID: 35060807 [TBL] [Abstract][Full Text] [Related]
7. Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm. Lee SS; McCue D; Pemmaraju N Expert Rev Anticancer Ther; 2020 Jul; 20(7):543-550. PubMed ID: 32460559 [TBL] [Abstract][Full Text] [Related]
8. FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Jen EY; Gao X; Li L; Zhuang L; Simpson NE; Aryal B; Wang R; Przepiorka D; Shen YL; Leong R; Liu C; Sheth CM; Bowen S; Goldberg KB; Farrell AT; Blumenthal GM; Pazdur R Clin Cancer Res; 2020 Feb; 26(3):532-536. PubMed ID: 31548341 [TBL] [Abstract][Full Text] [Related]
9. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in an Elderly Female: A Rare Case. Al-Alwan A; Khalid F; Vyas C; Sirpal V; Bader H J Community Hosp Intern Med Perspect; 2023; 13(4):79-81. PubMed ID: 37868236 [TBL] [Abstract][Full Text] [Related]
10. A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients. Gong C; Liu Y; Zhang M Ther Adv Hematol; 2024; 15():20406207241251602. PubMed ID: 38832237 [TBL] [Abstract][Full Text] [Related]
11. Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN). Alfayez M; Konopleva M; Pemmaraju N Expert Opin Biol Ther; 2020 Feb; 20(2):115-123. PubMed ID: 31801379 [No Abstract] [Full Text] [Related]
12. Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View. Di Raimondo C; Lozzi F; Di Domenico PP; Paganini C; Campione E; Galluzzo M; Bianchi L Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000208 [TBL] [Abstract][Full Text] [Related]
13. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy. Wilson NR; Konopleva M; Khoury JD; Pemmaraju N Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167 [TBL] [Abstract][Full Text] [Related]
15. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics. Adimora IJ; Wilson NR; Pemmaraju N Cancer; 2022 Aug; 128(16):3019-3026. PubMed ID: 35726525 [TBL] [Abstract][Full Text] [Related]